These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30739116)

  • 1. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey.
    Yalın SF; Eren N; Sinangil A; Yilmaz VT; Tatar E; Ucar AR; Sevinc M; Can Ö; Gurkan A; Arik N; Alisir Ecder S; Uyar M; Yasar M; Gulcicek S; Mese M; Dheir H; Cakir U; Köksal Cevher Ş; Turkmen K; Guven B; Guven Taymez D; Erkalma Senates B; Ecder T; Kocak H; Uslu A; Demir E; Basturk T; Ogutmen MB; Kinalp C; Dursun B; Bicik Bahcebasi Z; Sipahi S; Dede F; Oruc M; Caliskan Y; Genc A; Yelken B; Altıparmak MR; Turkmen A; Seyahi N
    Nephron; 2019; 142(1):26-33. PubMed ID: 30739116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey.
    Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S
    Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
    Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
    Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey.
    Huzmeli C; Candan F; Alaygut D; Bagci G; Akkaya L; Bagci B; Sozmen EY; Kurtulgan HK; Kayatas M
    Biochem Genet; 2016 Aug; 54(4):448-456. PubMed ID: 27105876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study.
    Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H
    Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening Test of Fabry Disease in Patients with Renal Replacement Therapy in the City of Modena].
    Alfano G; Ganda N; Cerami C; Mori G; Fontana F; Cappelli G
    G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy).
    Marrone G; Angelico R; Di Lauro M; Sargentini E; Manzia TM; Tisone G; Mitterhofer AP; Della Morte Canosci D; Tesauro M; Di Daniele N; Noce A
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3134-3141. PubMed ID: 37070916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
    Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
    Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
    Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of Fabry Disease Screening in Male Pre-End Stage Renal Disease Patients with Unknown Etiology Found Through the Platform of a Chronic Kidney Disease Education Program in a Northern Taiwan Medical Center.
    Lin CJ; Chien YH; Lai TS; Shih HM; Chen YC; Pan CF; Chen HH; Hwu WL; Wu CJ
    Kidney Blood Press Res; 2018; 43(5):1636-1645. PubMed ID: 30380558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
    Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
    Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Management of Fabry Disease in High-Risk Renal Disease Patients in Taiwan: A Single Center Study.
    Shih CY; You ZH; Tsai SF; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2023 May; 55(4):788-791. PubMed ID: 37230899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
    Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
    J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Fabry disease in patients with chronic kidney disease: A systematic review and meta-analysis.
    Linares D; Luna B; Loayza E; Taboada G; Ramaswami U
    Mol Genet Metab; 2023 Dec; 140(4):107714. PubMed ID: 37918171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995-2019.
    Capuano I; Garofalo C; Buonanno P; Pinelli M; Di Risi T; Feriozzi S; Riccio E; Pisani A
    J Nephrol; 2020 Jun; 33(3):569-581. PubMed ID: 31650418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic.
    Zemánek D; Januška J; Honěk T; Čurila K; Kubánek M; Šindelářová Š; Zahálková L; Klofáč P; Laštůvková E; Lichnerová E; Aiglová R; Lhotský J; Vondrák J; Dostálová G; Táborský M; Kasper D; Linhart A
    ESC Heart Fail; 2022 Dec; 9(6):4160-4166. PubMed ID: 36087038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
    Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
    Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of Fabry disease in a Turkish population with chronic kidney patients.
    Tomar ÖK; Bal AZ; Şirali SK; Duranay M; Korucu B; Güz G; Akdağ Sİ
    Int Urol Nephrol; 2023 Jun; 55(6):1629-1634. PubMed ID: 36725792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.
    Jahan S; Sarathchandran S; Akhter S; Goldblatt J; Stark S; Crawford D; Mallett A; Thomas M
    Orphanet J Rare Dis; 2020 Jan; 15(1):10. PubMed ID: 31931840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.
    Turkmen K; Guclu A; Sahin G; Kocyigit I; Demirtas L; Erdur FM; Sengül E; Ozkan O; Emre H; Turgut F; Unal H; Karaman M; Acıkel C; Esen H; Balli E; Bıtırgen G; Tonbul HZ; Yılmaz MI; Ortiz A
    Kidney Blood Press Res; 2016; 41(6):1016-1024. PubMed ID: 28006774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.